Heyuan Biotechnology (688238)
Overview
Shanghai Obio Technology (Group) Corp., Ltd., a biotechnology company, engages in the provision of technical services for the field of regenerative medicine and anti-aging in China. The company offers customized plasmid design and viral vector packaging services; AAV serotypes and tissue-specific promoters to support scientific research; and research grade, NHP Grade, cGMP grade vector manufacturing process, for basic research, translational research and clinical trials. It also provides CDMO se
Employees715
Market Cap$3.8B
Revenue$265.4M
Listed OnShanghai Stock Exchange
Ticker688238
CEOMr. Oudong Pan
HeadquartersShanghai